Abstract
Background: Lung cancer is the most commonly diagnosed cancer worldwide. 87% of cases are classified as NSCLC. NF1 is a tumour suppressor gene which limits RAS mediated signal transduction within the MAPK pathway. Up-regulation of this pathway leads to uncontrolled cellular proliferation. Somatic mutations in NF1 are reported in 8–12% of NSCLC patients. We hypothesise that NF1 variants have a functional consequence on the activation of the MAPK pathway.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical oncology (Royal College of Radiologists (Great Britain))
Paper Title
Journal
Date
